Drug application
FOSAPREPITANT DIMEGLUMINE (FOSAPREPITANT DIMEGLUMINE)
Drugs@FDA ANDA 214616 · ASPIRO
Key facts
| Drug name | FOSAPREPITANT DIMEGLUMINE |
|---|---|
| Active ingredients | FOSAPREPITANT DIMEGLUMINE |
| Application type | ANDA |
| Application number | 214616 |
| Company | ASPIRO |
| Dosage forms | POWDER, INTRAVENOUS |
| Strength | EQ 150MG BASE/VIAL |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Jul 29, 2021 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.